Skip to main content
. 2015 Oct 29;6:248. doi: 10.3389/fphar.2015.00248

Figure 4.

Figure 4

Representative graphs of split RMSD of VEGFA (black line) and anti-VEGF (red line) binding domains. (A) Split RMSD for the ranibizumab/VEGFA complex; (B) split RMSD for Fab-bevacizumab/VEGFA complex; (C) split RMSD for VEGFR1d2_R2d3/VEGFA complex.